Boston Scientific logo

BSX PR A - Boston Scientific News Story

$122.43 6.4  5.6%

Sector
Healthcare
Size
Large Cap
Market Cap £44.95bn
Enterprise Value £49.62bn
Revenue £8.14bn
Position in Universe th / 7247

BUZZ-BTIG says COVID-19 uncertainty looms despite vaccinations push

Tue 14th September, 2021 5:26pm
** Brokerage BTIG says near-term uncertainty regarding
COVID-19 case rates persists despite the U.S. government's
efforts to push up vaccinations as students head back to school
coupled with the potential danger from new, contagious variants
    ** Brokerage spoke to two key opinion leaders (KOLs), who
noted a small uptick in COVID-19 hospitalizations and strain on
ICU capacity due to the Delta coronavirus variant, however the
impact was not as disruptive as it was early into the pandemic
    ** BTIG says it felt optimistic about hospital preparedness
to tackle a potential hospitalization surge in the New England
and the Mid-Atlantic regions, where the KOLs are from
    ** Expects respiratory products maker Vapotherm  VAPO.N ,
and Inari Medical Inc  NARI.N , which sells devices to remove
blood clots, to keep benefiting from new hospitalization surges;
says Masimo  MASI.O  may see greater demand for its patient
monitoring products
    ** Brokerage cautions of a hit to some medical device makers
including Abbott Labs  ABT.N , Boston Scientific Corp  BSX.N ,
Edwards Lifesciences  EW.N , AtriCure Inc  ATRC.O , Abiomed
 ABMD.O  and Acutus Medical Inc  AFIB.O 
    ** However, any near-term impact is likely to be temporary
as already demonstrated by the rapid recovery in procedure
volumes during Q2- brokerage

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.